This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Goals of medical management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The outcome of treatment is likely to depend on the stage at which the breast cancer presents.

Stage I and II disease (ie local nodal involvement, but nodes not fixed), accounts for about 80% of breast cancer. It may be regarded as "curable." Local control is by wide local excision (WLE) with axillary node dissection and radiotherapy, or by simple mastectomy. Modified radical mastectomy is now, only occasionally advised. Chemotherapy and/or hormonal therapy may be used for systemic control.

For stage III and IV (ie locally advanced disease or distant metastasis), the goals of treatment are to control local disease and to improve the quality of life. Most die of distant metastases. Surgery is tailored to the individual, and is limited to "salvage" mastectomy. Chemotherapy and radiotherapy are the dominant treatment modalities.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.